BIE — Bioera SpA Share Price
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | n/a | ||
Operating Margin | 773.43% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | €m | 28.02 | 11.83 | 1.19 | 4.67 | 1.6 | n/a | n/a | -47.82% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Bioera SpA is an Italy-based company engaged in the production and distribution of organic products, natural cosmetics and traditional food products. The company’s activities are divided into two sectors. The Biological and Natural products sector, through its subsidiaries and affiliated entities, is active in the distribution of natural and organic products; production of organic food from vegetables; manufacture of oil from organic agriculture, and distribution of traditional food products, as well as in the sector of natural origin cosmetics. The Holding sector provides activities of the Company as a parent of the group. The Company controls entities, such as Organic Oils Italia Srl, La Fonte della Vita Srl, KI Group SpA and Organic Food Retail Srl.
Directors
- Daniela Garnero Santanche CHM
- Canio Mazzaro CEO (62)
- Davide Mantegazza NVC (56)
- Fiorella Garnero DRC
- Gianni Berton IND
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- January 1st, 1970
- Public Since
- July 27th, 2005
- No. of Employees
- 2
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
Borsa Italiana
- Shares in Issue
- 20,571,040

- Address
- Corso Di Porta Nuova 46, MILANO, 20121
- Web
- http://www.bioera.it/it
- Phone
- +39 0236695124
- Auditors
- RSM Societa di Revisione e Organizzazione Contabile SpA
Upcoming Events for BIE
Similar to BIE
BF SpA
Borsa Italiana
Centrale del Latte d'Italia SpA
Borsa Italiana
Enervit SpA
Borsa Italiana
Fine Foods & Pharmaceuticals NTM SpA
Borsa Italiana
High Quality Food SpA
Borsa Italiana
FAQ
As of Today at 19:36 UTC, shares in Bioera SpA are trading at €0.04. This share price information is delayed by 15 minutes.
Shares in Bioera SpA last closed at €0.04 and the price had moved by +31.33% over the past 365 days. In terms of relative price strength the Bioera SpA share price has outperformed the FTSE Global All Cap Index by +29.02% over the past year.
There is no consensus recommendation for this security.
Find out moreBioera SpA does not currently pay a dividend.
Bioera SpA does not currently pay a dividend.
Bioera SpA does not currently pay a dividend.
To buy shares in Bioera SpA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €0.04, shares in Bioera SpA had a market capitalisation of .
Here are the trading details for Bioera SpA:
- Country of listing: Italy
- Exchange: MIL
- Ticker Symbol: BIE
Based on an overall assessment of its quality, value and momentum Bioera SpA is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioera SpA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -46.11%.
As of the last closing price of €0.04, shares in Bioera SpA were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Bioera SpA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €0.04.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Bioera SpA's management team is headed by:
- Daniela Garnero Santanche - CHM
- Canio Mazzaro - CEO
- Davide Mantegazza - NVC
- Fiorella Garnero - DRC
- Gianni Berton - IND